The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.

导出 LinkOut

翻译打印收藏纠错

作者： Carey K,Anders ^[1] ; Vandana,Abramson ^[1] ; Tira,Tan ^[1] ; Rebecca,Dent ^[1]

作者单位： From the Department of Medicine, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, TN; Department of Medicine, National Cancer Center Singapore, Singapore; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC. ^[1]

主题词女(雌)性(Female);人类(Humans);分子靶向治疗(Molecular Targeted Therapy);突变(Mutation);肿瘤辅助疗法(Neoadjuvant Therapy);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);预后(Prognosis);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)

DOI 10.1200/EDBK_159135

PMID 27249684

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览7

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

2016年35卷

34-42页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

相似文献

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

相似文献

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

相关期刊

检索历史清除